NCT00952952View on ClinicalTrials.gov

Trial of Mesalamine for the Treatment of Active Microscopic Colitis

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Microscopic ColitisDiarrhea

Interventions

DRUG

Mesalamine

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Paul E. Evans MD

UNKNOWN

collaborator

William J. Sandborn MD

UNKNOWN

collaborator

Edward V. Loftus MD

UNKNOWN

collaborator

Thomas C. Smryk MD

UNKNOWN

collaborator

Willaim Tremaine MD

UNKNOWN

lead

Mayo Clinic

OTHER